Abstract
BackgroundAnti-TNF drugs are an effective therapy for patients (pts) with rheumatoid arthritis (RA) but are associated with an increased incidence of serious infectious events (SIEs). We have previously identified baseline...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
